UnknownPhase 4NCT01915485

Radiolabeled Molecules for Medullary Thyroid Cancer

Studying Medullary thyroid carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Cancer, Brazil
Principal Investigator
Fernanda Vaisman, MD, PhD
National Cancer Institute, France
Intervention
Lu 177(radiation)
Enrollment
20 target
Eligibility
18 years · All sexes
Timeline
2013 – 2017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01915485 on ClinicalTrials.gov

Other trials for Medullary thyroid carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Medullary thyroid carcinoma →

← Back to all trials